Related Experiment Video

Updated: Jul 20, 2026

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

Regulatory failure of serum prohepcidin levels in patients with hepatitis C

Miki Nagashima1, Masatoshi Kudo, Hobyung Chung

  • 1Department of Gastroenterology and Hepatology, Kinki University School of Medicine, 377-2, Ohno-Higashi, Osaka-sayama, Osaka 589-8511, Japan.

Hepatology Research : the Official Journal of the Japan Society of Hepatology
|September 19, 2006
PubMed

Insights

Hepatitis C virus infection may disrupt serum prohepcidin regulation, leading to elevated ferritin and iron overload, potentially worsening liver injury. This contrasts with findings in hepatitis B virus patients.

Area of Science:

  • Hepatology
  • Iron Metabolism
  • Viral Hepatitis

Background:

  • Chronic hepatitis C (CHC) often presents with elevated serum ferritin and hepatic iron.
  • The role of hepcidin, a key iron-regulating hormone, in CHC is not well understood.

Purpose of the Study:

  • To investigate the relationship between serum hepcidin and iron status markers in patients with viral hepatitis.
  • To compare hepcidin levels in patients with hepatitis C virus (HCV) and hepatitis B virus (HBV) infection.

Main Methods:

  • Measured serum prohepcidin levels in patients with HCV, HBV, and healthy controls.
  • Assessed correlations between serum prohepcidin, ferritin, and liver iron scores.
  • Compared serum prohepcidin levels between different hepatitis groups and disease severities.

Main Results:

  • Serum prohepcidin and ferritin showed a negative correlation in HCV patients, unlike in HBV patients and controls.
  • Liver iron scores were negatively correlated with serum prohepcidin in HCV patients.
  • Serum prohepcidin levels were significantly lower in HCV patients compared to HBV patients, especially in those with liver cirrhosis.

Conclusions:

  • HCV infection may impair the homeostatic regulation of serum prohepcidin.
  • This dysregulation could contribute to elevated ferritin and iron overload, potentially driving liver injury progression in CHC.
  • Hepcidin regulation differs between HCV and HBV infections.
Abstract

More Related Videos

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection10:25

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection

Published on: February 19, 2019

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...